3 Numbers From Viking Therapeutics' Weight-Loss Drug Trial That Have Wall Street Buzzing
Key PointsThe company's key drug continues to demonstrate it can produce rapid weight loss in people with obesity.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.